MedPharm Secured New Commercial Manufacturing Deal
The company will produce a branded topical pharmaceutical product at its Durham facility.
Updated on Oct. 2, 2026 in Healthcare
Live Poll
Is the growth of pharmaceutical manufacturing outsourcing in your area good for the local economy?
MedPharm has signed a commercial site transfer agreement to manufacture a branded speciality topical pharmaceutical product. The work will be carried out at the company’s facility in Durham, North Carolina.
Why it matters
This partnership marks the latest expansion of manufacturing services provided by the Durham site. It signals continued growth for the company's clinical and commercial drug product operations.
This deal is the fifth commercial contract MedPharm has secured in the last eighteen months. Technology transfer revenues are projected for 2026 and 2027, followed by commercial manufacturing revenue in 2027.
The players
MedPharm
MedPharm is a company that provides technical transfer services and clinical and commercial drug product manufacturing.
FDA
The Food and Drug Administration is the federal agency responsible for protecting public health by ensuring the safety and efficacy of medical products.
The details
The Durham facility is equipped to handle comprehensive product manufacturing including formulation, process development, packaging, testing, and release. MedPharm completed an FDA inspection of this commercial manufacturing site in 2026 to ensure it meets required standards.
Timeline
October 2, 2026: The commercial site transfer agreement was officially announced.
August 2026: MedPharm became an Olink Certified Service Provider.
2026 and 2027: Technology transfer revenues are expected to be generated.
2027: Commercial manufacturing revenues are expected to begin.
Market Landscape
The contract underscores a trend of pharmaceutical companies outsourcing specialized topical manufacturing to regional contract service providers. This partnership reinforces MedPharm's position within the competitive landscape of clinical and commercial drug product manufacturing.
This deal primarily impacts industry partners and stakeholders rather than retail shoppers or patients. It highlights the growing industrial capabilities of the local healthcare sector in Durham.
The takeaway
Securing five commercial deals in eighteen months highlights the company's successful integration of technology transfer services. This expansion reflects a steady growth trajectory for specialized pharmaceutical manufacturing in the region.
Further reading
Learn more about local industry developments in Healthcare.
Live Poll
Is the growth of pharmaceutical manufacturing outsourcing in your area good for the local economy?
